awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39433254-8A786C1E-CEF2-4C10-8CB7-94AFA8575066
Q39433254-8A786C1E-CEF2-4C10-8CB7-94AFA8575066
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39433254-8A786C1E-CEF2-4C10-8CB7-94AFA8575066
The safety of available treatments options for neuroendocrine tumors.
P2860
Q39433254-8A786C1E-CEF2-4C10-8CB7-94AFA8575066
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39433254-8A786C1E-CEF2-4C10-8CB7-94AFA8575066
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92c7d94e54c1b95a894dd9bcc91de8ecd3f736d3
P2860
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.